Product correctly added to cart.

discount label
Salinosporamide A
View 3D

Biosynth logo

Salinosporamide A

CAS: 437742-34-2

Ref. 3D-FS36376

25µgTo inquire
50µgTo inquire
100µgTo inquire
250µgTo inquire
500µgTo inquire
Estimated delivery in United States, on Friday 16 Aug 2024

Product Information

Name:
Salinosporamide A
Description:

Salinosporamide A is a novel anti-cancer compound that belongs to the class of aldol cyclization reaction. It is an irreversible inhibitor of protein kinase C and has been shown to inhibit growth factor-induced cell proliferation in vitro. Salinosporamide A also inhibits the production of nitric oxide, which may be involved in the inhibition of growth factor-induced cell proliferation in vitro. Salinosporamide A is selective for cAMP-dependent protein kinase, but not for other protein kinases such as Ca2+/calmodulin-dependent protein kinase II and Ca2+/calmodulin-dependent protein kinase IV. Salinosporamide A has also shown effectiveness against infectious diseases caused by bacteria and fungi. It acts by inhibiting the synthesis of DNA, RNA, and proteins.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
313.78 g/mol
Formula:
C15H20ClNO4
Purity:
Min. 95%
Color/Form:
White Powder
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FS36376 Salinosporamide A

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".